Tetrandrine down-regulates expression of miRNA-155 to inhibit signal-induced NF-κB activation in a rat model of diabetes mellitus

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 3, 2015, Pages 4024-4030

  Song, Chunhui ^a   Ji, Yunxi ^b   Zou, Guohui ^c   Wan, Chunxia ^d  

^a JIANGXI NORMAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^c Department of Cardiology The First Affiliated Hospital of Jiangxi University of Chinese Medicine   (China)

^d Department of Integrative Medicine Corps Hospital of Armed Police   (China)

Author keywords

Diabetes mellitus; MiRNA 155; NF B; Tetrandrine; TNF

Indexed keywords

ALLOXAN; BETA ACTIN; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN A1C; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MALONALDEHYDE; MESSENGER RNA; MICRORNA 155; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TETRANDRINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; INTRACELLULAR SIGNALING; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

RATTUS;

EID: 84929379052     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ruscica M, Macchi C, Morlotti B, Sirtori CR and Magni P. Statin therapy and related risk of new-onset type 2 diabetes mellitus. Eur J Intern Med 2014; 25: 401-6.
2. Li Y, Yang Y, Shi L, Li X, Zhang Y and Yao Y. The association studies of ADIPOQ with type 2 diabetes mellitus in Chinese populations. Diabetes Metab Res Rev 2012; 28: 551-9.
3. Zhang ZJ. Re: “Type 2 diabetes and the risk of colorectal adenomas: Black Women’s Health Study”. Am J Epidemiol 2014; 179: 1276-7.
4. Puls M, Bleckmann A, Jacobshagen C, Danner BC, Hasenfuß G, Seipelt R and Schillinger W. Diabetes increases short- and long-term mortality after transcatheter aortic valve implantation (TAVI). Dtsch Med Wochenschr 2014; 139: 822-8.
5. Kempf K. Patterns of weight development before the diagnosis of type 2 diabetes--Moderate overweight should not increase--in total, overweight should be reduced. Dtsch Med Wochenschr 2014; 139: 818.
6. Preshaw P. Summary of: type 2 diabetes risk screening in dental practice settings: a pilot study. Br Dent J 2014; 216: 416-7.
7. Leidig-Bruckner G, Grobholz S, Bruckner T, Scheidt-Nave C, Nawroth P and Schneider JG. Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus. BMC Endocr Disord 2014; 14: 33.
8. Rioja J, Moreno T, Coca I, Jiménez-Villodres M, Rodríguez-Morata A and Valdivielso P. [Preliminary analysis of the relationship between peripheral arterial disease and other atherosclerosis markers and diabetic nephropathy]. Clin Investig Arterioscler 2014; 26: 229-35.
9. Fujihara K, Suzuki H, Sato A, Ishizu T, Kodama S, Heianza Y, Saito K, Iwasaki H, Kobayashi K, Yatoh S, Takahashi A, Yahagi N, Sone H and Shimano H. Comparison of the Framingham Risk Score, UK Prospective Diabetes Study (UKPDS) Risk Engine, Japanese Atherosclerosis Longitudinal Study-Existing Cohorts Combine (JALS-ECC) and maximum carotid intima-media thickness for predicting coronary artery stenosis. J Atheroscler Thromb 2014; 21: 799-815.
10. Kumar V, Mahdi F, Khanna AK, Singh R, Chander R, Saxena JK, Mahdi AA and Singh RK. Antidyslipidemic and Antioxidant Activities of Hibiscus rosa sinensis Root Extract in Alloxan Induced Diabetic Rats. Indian J Clin Biochem 2013; 28: 46-50.
11. Chen Y, Tsai YH and Tseng SH. The potential of tetrandrine as a protective agent for ischemic stroke. Molecules 2011; 16: 8020-32.
12. Sun GR, Zhang GF, Wei YJ, Yang DS, Zhang JX and Tian ZB. [Protective effect of tetrandrine on pancreatic islet cells damaged by alloxan in rats]. Sheng Li Xue Bao 1994; 46: 161-7.
13. Wang Y, Ma W and Zheng W. Deguelin, a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemoprevention. Mol Clin Oncol 2013; 1: 215-219.
14. Elton TS, Selemon H, Elton SM and Parinandi NL. Regulation of the MIR155 host gene in physiological and pathological processes. Gene 2013; 532: 1-12.
15. Nahid MA, Satoh M and Chan EK. MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol 2011; 8: 388-403.
16. McDaniel K, Herrera L, Zhou T, Francis H, Han Y, Levine P, Lin E, Glaser S, Alpini G and Meng F. The functional role of microRNAs in alcoholic liver injury. J Cell Mol Med 2014; 18: 197-207.
17. Li X, Tian F and Wang F. Rheumatoid arthritis-associated microRNA-155 targets SOCS1 and upregulates TNF-α and IL-1β in PBMCs. Int J Mol Sci 2013; 14: 23910-21.
18. Wang G, Kwan BC, Lai FM, Chow KM, Li PK and Szeto CC. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis Markers 2011; 30: 171-9.
19. Sun G, Qi Y and Pan Q. Quantitative analysis of prevention effect of tetrandrine on pancreatic islet beta cells injury in rats. Zhonghua Yi Xue Za Zhi 1997; 77: 270-3.
20. He BC, Gao JL, Zhang BQ, Luo Q, Shi Q, Kim SH, Huang E, Gao Y, Yang K, Wagner ER, Wang L, Tang N, Luo J, Liu X, Li M, Bi Y, Shen J, Luther G, Hu N, Zhou Q, Luu HH, Haydon RC, Zhao Y and He TC. Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol 2011; 79: 211-9.